Strain Differences Separate Helpful and Harmful Elements of the Human Microbiome
|
By LabMedica International staff writers Posted on 12 Mar 2013 |
A recent microbiome study demonstrated the importance of evaluating bacteria at the strain rather than the genus or species level in order to understand their contribution to human health or disease.
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Latest BioResearch News
- Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
- Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
- Lysosomal Gene Defect Linked to Severe Childhood Brain Disorders
- Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals
- Hidden 'Jumping Gene' Variant Linked to Higher Pancreatic Cancer Risk
- Common White Blood Cells Produce Schizophrenia-Linked Protein
- Nanopore Method Captures RNA Folding at Single-Molecule Resolution
- Tumor Microenvironment Marker Linked to Worse Survival in Solid Tumors
- Hidden Immune Gene Defect May Explain Kaposi Sarcoma Susceptibility
- Genetic Markers May Help Predict Amputation Risk in Peripheral Artery Disease
- Gene Signature Shows Promise for Depression Biomarker Testing
- AI-Driven Tumor Profiling Initiative Targets Precision Therapy Development
- Researchers Map Protein and Glycosylation Across 15 Human Body Fluids
- Telomere Length Abnormalities Linked to Lymphoma Development
- Biomarker Signals Chemotherapy Resistance in Relapsed Small Cell Lung Cancer
- Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence
Channels
Clinical Chemistry
view channel
Urine-Based Test Shows Promise for Autism Screening in Children
Autism spectrum disorder (ASD) is commonly diagnosed through behavioral assessments, which can involve long waits that delay intervention. Earlier identification is linked to better developmental outcomes,... Read more
Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis
Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read moreMolecular Diagnostics
view channel
Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests
Colorectal cancer is the second-leading cause of cancer death in the United States and claimed an estimated 55,000 lives in 2026. Incidence is rising among adults younger than 50, even as overall mortality... Read more
Digital PCR Assays Support Surveillance of Bundibugyo Ebolavirus Outbreak
QIAGEN (Venlo, Netherlands) has introduced two custom-designed research-use-only (RUO) QIAcuity dPCR assays to support infectious disease research and surveillance connected to the Bundibugyo ebolavirus outbreak.... Read more
Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channel
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read more
Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects nearly 3 million people in the United States and its prevalence continues to rise. Medications that target tumor necrosis factor (TNF)-alpha are widely used, but... Read moreMicrobiology
view channel
Gut Microbiome Signatures Help Identify Risk of IBD Progression
Inflammatory bowel disease (IBD), encompassing Crohn’s disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract with highly variable outcomes.... Read more
FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
Clinical guidelines support testing based on patient presentation in suspected gastrointestinal infections, yet available technologies have often forced laboratories to choose between panels that are too... Read morePathology
view channel
AI-Powered Atlas Maps Immune Structures Linked to Cancer Outcomes
Tertiary lymphoid structures are emerging as important indicators of antitumor immunity, but their heterogeneity and spatial context within tumors remain difficult to capture through routine diagnostics.... Read more
AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy
Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read moreTechnology
view channel
Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
Colorectal cancer screening is a longstanding preventive priority, yet participation and follow-up remain uneven across patient groups. Safety‑net primary care settings often face barriers that limit screening... Read more
Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
Chronic liver disease is common and often progresses silently, increasing the risk of cirrhosis and hepatocellular carcinoma when not detected early. With an estimated 1.5 billion people affected worldwide... Read moreIndustry
view channelWerfen and Oxford Nanopore Collaborate on Transplant Assay Development
Werfen (Barcelona, Spain), a global specialized diagnostics company, has announced a strategic collaboration with Oxford Nanopore Technologies (Oxford, UK), which develops nanopore-based sequencing technology,... Read more








